66% hadune nethi eka special added benefit ekak ban. eka neme vaccine eke balaporoththuwa. dan tiyena vaccines ekka baluwama 66% prevention kiyanneme loku win ekak. dan tiyena kisi vaccine ekak guaranty ekk denne ne prevention eka gana.අනේ බන්
නිවුස් එෙකේම තියෙනවා 66%යි වැඩ කලේ කියලා
අනික් 34% කොවිඩ් හැදිලා කුකුලෝ
උඹයි උඹේ ගණනුයි නම්
India wa ne hadanneDNA vaccines very effective but also very dangerous. hari giyot hari giya, kela unot parampara ganakatama kela wenawa

me Rahukethu vaccine eka wage covid walata ekak hoyaganna beriweida danne ne?We have our one for dengue.
View attachment 140080
Findings
Out of 126 individuals screened for eligibility. Forty-eight subjects (mean age 34·9 years) were enrolled and vaccinated in the Phase 1 study Overall, 12/48 (25%) subjects reported at least one AE (i.e. combined solicited and unsolicited) during the study. There were no deaths or serious adverse events reported in Phase 1 of the study. The proportion of subjects who seroconverted based on IgG titers on day 84 was 4/11 (36·36%), 4/12 (33·33%), 10/10 (100·00%) and 8/10 (80·00%) in the treatment Arm 1 (1 mg: Needle), Arm 2 (1 mg: NFIS), Arm 3 (2 mg: Needle) and Arm 4 (2 mg: NFIS), respectively.
oka hadapu ekatha ratin paneeda danne naha?